Testing effectiveness (Phase 2)Study completedNCT00627146
What this trial is testing
Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients
Who this might be right for
Diabetes Mellitus, Type 1
Universitair Ziekenhuis Brussel 80